-+ 0.00%
-+ 0.00%
-+ 0.00%
MyGenome wins MS ISO 15189:2022 accreditation for whole genome sequencing
Share
Listen to the news
MyGenome wins MS ISO 15189:2022 accreditation for whole genome sequencing
  • MyGenome, a unit of Alps Group, received MS ISO 15189:2022 accreditation for whole genome sequencing.
  • Accreditation supports clinical-grade use of MyGenome’s WGS data, strengthening eligibility for hospital, research, government, cross-border partnerships.
  • Move broadens addressable market in Southeast Asia for WGS services under an internationally recognized medical laboratory standard.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alps Group Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606090805PRIMZONEFULLFEED9733393) on June 09, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending